Journal issues > Issue 5, December 2014 > High-risk localised prostate cancer: the role of surgery and the development of clinical outcome prediction models

High-risk localised prostate cancer: the role of surgery and the development of clinical outcome prediction models

By: S. Joniau MD, PhD, H. Van Poppel MD, PhD

This PhD thesis is aimed at elucidating some very important issues on high-risk prostate cancer: How can high-risk prostate cancer best be defined? Can we clearly define demarcated prognostic subgroups within the high-risk prostate cancer group which could allow improved patient counselling, comparison of different treatment strategies and proper trial design? What are the outcomes of surgery in high-risk prostate cancer and how can we identify those patients within the heterogeneous group of high-risk prostate cancer who would benefit most from surgery?

(BELG J MED ONCOL 2014;8(5):220–3)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top